ThermoGenesis, TotipotentRx to merge as Cesca
This article was originally published in Scrip
Executive Summary
ThermoGenesis and TotipotentRx (TotiRx) will merge in an all-stock deal to create one public company named Cesca Therapeutics that is focused on processing and storing stem cells as well as developing cell-based therapies.